在卵巢癌中对CCAAT/增强剂结合蛋白家族进行全面分析

Jiahong Tan1, Daoqi Wang2, Wei Dong1

  • 1Department of Obstetrics and Gynecology, National Key Clinical Specialty of Gynecology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, People's Republic of China.

Cancer informatics
|September 6, 2024
PubMed
概括

CCAAT/增强剂结合蛋白 (C/EBP) 是卵巢癌的关键. 描述这些转录因子揭示了它们在生存,药物反应和免疫透中的作用,表明它们作为生物标志物的潜力.